Filing metadata

Accession number
0001209191-21-010241
Form type
Form 5
Filer
Marker Therapeutics, Inc.
CIK
CIK 1094038
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Annual insider statement

Explore SEC Filings Hub